A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice

Clinical trial NCT05637112 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05637112
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Systemic Lupus Erythematosus

Start date: 2023-02-27
Primary completion: 2030-12-30
Enrollment: 551

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.